БЛОГ

Archive for the ‘biotech/medical’ category: Page 630

May 3, 2023

The Role of Chat-GPT in Improving Mental Health Care and Therapy

Posted by in categories: biotech/medical, neuroscience, robotics/AI

Given the rise of chat gpt and its volumes of knowledge bases there is a new chat bot that is aiding mental health care and therapy 😀


When it comes to mental health, the main focus is on the patient and how to provide the best care possible. But with the rising demand for mental health services, it’s increasingly difficult for clinicians to address the individual needs of their patients and meet the growing demand for mental health services. This is where ChAT-GPT, or Conversational Artificial intelligence-based Therapy for Generalized Psychological Treatment, comes in.

Chat-GPT is an AI-based therapy that uses natural language processing (NLP) and conversational AI to help therapists provide more personalized and effective mental health care and therapy. This new technology allows mental health professionals to provide real-time and personalized care to their patients in a way that is tailored to their needs and preferences. In this article, we will discuss the key features of Chat-GPT and how it is helping improve mental health care and therapy.

Chat-GPT is a type of AI-based therapy developed by researchers at Albert Einstein College of Medicine. It is a conversational AI-based therapy designed to help clinicians diagnose mental health issues. Chat-GPT uses natural language processing (NLP) to understand the patient’s conversations and provide personalized care and therapy.

Continue reading “The Role of Chat-GPT in Improving Mental Health Care and Therapy” »

May 3, 2023

Cell Therapy AIDS Stroke-Damaged Brain Repair, Restores 90% of Motor Function

Posted by in categories: biotech/medical, mobile phones, neuroscience

Year 2021 face_with_colon_three This could be made into a smartphone device that could one day treat everything without the need for surgery or other ways that are not as safe.


Researchers are investigating potential uses for the cell reprogramming technology to treat brain disorders such as Alzheimer’s disease or autoimmune diseases.

Continue reading “Cell Therapy AIDS Stroke-Damaged Brain Repair, Restores 90% of Motor Function” »

May 3, 2023

World’s first bladder transplant will be performed by both human and robot surgeons

Posted by in categories: biotech/medical, robotics/AI

For the first time in human history, doctors will transplant a human bladder from a deceased person to an alive patient using surgery robots.

A team of urologists at Keck Medicine of the University of South California (USC) is conducting a clinical trial that will soon lead to the first-ever bladder transplant operation in humans. The doctors are currently in the process of selecting participants for their trials.

If successful, such operations would provide relief to millions of people around the globe who live with bladder-related disorders.

Continue reading “World’s first bladder transplant will be performed by both human and robot surgeons” »

May 3, 2023

This is not a drill: IBM freezes hiring, could replace 7,800 jobs with AI

Posted by in categories: biotech/medical, employment, robotics/AI

HJBC/iStock.

The long-standing argument against AI fully replacing humans has been that the technology doesn’t yet possess the emotional bandwidth and cognitive ability that humans have. But we are a daily witness to the growth of artificial intelligence in areas of art, medicine, and scientific research.

May 3, 2023

From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis

Posted by in categories: biotech/medical, chemistry

Indigo naturalis is a blue dye in ancient, as well as an extensive used traditional Chinese medicine. It has a wide spectrum of pharmacological properties and can be used to treat numerous ailments such as leukemia, psoriasis, and ulcerative colitis. This article aims to expand our understanding of indigo naturalis in terms of its chemical constituents, pharmacological action and clinical applications.

We searched PubMed, web of science, CNKI, Google academic, Elsevier and other databases with the key words of “Indigo naturalis”, and reviewed and sorted out the modern research of indigo naturalis based on our research results.

We outlined the traditional manufacturing process, chemical composition and quality control of indigo naturalis, systematically reviewed traditional applictions, pharmacological activities and mechanism of indigo naturalis, and summarized its clinical trials about treatment of psoriasis, leukemia and ulcerative colitis.

May 3, 2023

New Indigo Light Kills Bacteria at Hospitals

Posted by in categories: biotech/medical, chemistry, health

Year 2015 😗😁


Indigo-Clean is a new light that is capable of killing bacteria. Used in a healthcare settings, the device could help prevent the spread of dangerous microorganisms, including Methicillin-resistant Staphylococcus aureus (MRSA), a bacterium responsible for several difficult-to-treat infections in humans.

Bacteria in the air absorb the indigo-colored light, which then creates a chemical reaction within the microorganism. This creates an environment that acts like bleach, killing the microscopic lifeform, reports Tech Times.

Continue reading “New Indigo Light Kills Bacteria at Hospitals” »

May 3, 2023

Can veganism really lower a person’s COVID-19 risk?

Posted by in category: biotech/medical

Year 2021 I have tried this diet and it nearly eliminates lots of diseases aswell as covid 19 spread it is like some sorta code for keeping one essentially super resistant to covid 19 symptoms.


A plant-based or vegan diet cannot prevent people from developing COVID-19. They may, however, help support the immune system and aid in prevention. Learn more.

May 3, 2023

Mechanism resembling aging and cancer found in a Finnish mitochondrial disease

Posted by in categories: biotech/medical, genetics, life extension

A study has found that a mitochondrial disease in newborns shows cancer-like changes in proliferating cells, causing tissues to age prematurely. The finding is a significant step forward in understanding the syndrome and developing treatments for mitochondrial diseases.

GRACILE syndrome, a that is one of the Finnish heritage diseases, shows altered and proliferation resembling that of . In the future, similar could potentially be treated by limiting excessive cell proliferation. This is demonstrated in a study led by docent Jukka KallijÀrvi and professor emerita Vineta Fellman that was carried out at the FolkhÀlsan Research Center and the University of Helsinki and published in Nature Communications in April 2023.

Mitochondria are organelles responsible for a large portion of cellular energy metabolism. Mutations in genes required for mitochondrial functions cause mitochondrial diseases in humans. GRACILE syndrome is caused by a malfunction in the respiratory chain, the very system the mitochondria utilize to generate cellular energy. The onset of the syndrome is in the fetal period, manifesting after birth as a liver and kidney disease with severe metabolic complications. Newborns with the syndrome usually only survive a few weeks.

May 3, 2023

Chemotherapy drug reaches brain in humans for first time

Posted by in categories: biotech/medical, neuroscience

https://youtube.com/watch?v=KSDhqhKL-JQ

A major impediment to treating the deadly brain cancer glioblastoma has been that the most potent chemotherapy can’t permeate the blood-brain barrier to reach the aggressive brain tumor.

But now Northwestern Medicine scientists report results of the first in-human clinical trial in which they used a novel, skull-implantable ultrasound device to open the and repeatedly permeate large, critical regions of the to deliver chemotherapy that was injected intravenously.

Continue reading “Chemotherapy drug reaches brain in humans for first time” »

May 3, 2023

Study offers fresh hope for people living with chronic back pain

Posted by in categories: biotech/medical, health

Long-term sufferers of chronic back pain experienced dramatic reductions in pain and related disability that remained at their one-year follow-up after taking part in a new treatment tested by Curtin-Macquarie-Monash University research.

Published today in the journal The Lancet, the research found large clinically significant improvements in the intensity of pain and pain-related disability among almost 500 people who had been seeking help for their pain for an average of four years before trialing the new treatment.

The treatment, which delivered a health care and work productivity saving of more than $5,000 per person, took a whole-person approach by also helping people to make lifestyle changes aimed at improving their social and emotional health.

Page 630 of 2,734First627628629630631632633634Last